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Frank M Brunkhorst2,5† and Hubertus Axer1,2*†Abstract
Introduction: Muscle ultrasound is emerging as a promising tool in the diagnosis of neuromuscular diseases. The
current observational study evaluates the usefulness of muscle ultrasound in patients with severe sepsis for
assessment of critical illness polyneuropathy and myopathy (CINM) in the intensive care unit.
Methods: 28 patients with either septic shock or severe sepsis underwent clinical neurological examinations,
muscle ultrasound, and nerve conduction studies on days 4 and 14 after onset of sepsis. 26 healthy controls of
comparable age underwent clinical neurological evaluation and muscle ultrasound only.
Results: 26 of the 28 patients exhibited classic electrophysiological characteristics of CINM, and all showed typical clinical
signs. Ultrasonic echogenicity of muscles was graded semiquantitatively and fasciculations were evaluated in muscles of
proximal and distal arms and legs. 75% of patients showed a mean echotexture greater than 1.5, which was the maximal
value found in the control group. A significant difference in mean muscle echotexture between patients and controls was
found at day 4 and day 14 (both p < 0.001). In addition, from day 4 to day 14, the mean grades of muscle echotexture
increased in the patient group, although the values did not reach significance levels (p = 0.085). Controls revealed the
lowest number of fasciculations. In the patients group, fasciculations were detected in more muscular regions (lower and
upper arm and leg) in comparison to controls (p = 0.08 at day 4 and p = 0.002 at day 14).
Conclusions: Muscle ultrasound represents an easily applicable, non-invasive diagnostic tool which adds to
neurophysiological testing information regarding morphological changes of muscles early in the course of sepsis. Muscle
ultrasound could be useful for screening purposes prior to subjecting patients to more invasive techniques such as
electromyography and/or muscle biopsy.
Trial registration: German Clinical Trials Register, DRKS-ID: DRKS00000642.Introduction
Critical illness polyneuropathy (CIP) and critical illness
myopathy (CIM) as well as the combination of both are
common sequelae in patients with severe sepsis in ICUs
[1-3]. The common clinical feature of unclassified CIM
and CIP comprises ICU-acquired weakness (ICUAW).
About 70% of patients with severe sepsis develop alter-
ations of the peripheral nervous system [4,5]. Whereas* Correspondence: hubertus.axer@med.uni-jena.de
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reproduction in any medium, provided the orsymmetric distally predominant muscle weakness with
atrophy, loss of deep tendon reflexes, and often a distal
reduction of sensitivity to pain, temperature, and vibra-
tion are typical clinical features of CIP [6], early failure of
weaning from the ventilator and proximal muscle weak-
ness are more suggestive of CIM. Development of CIP
contributes to longer ventilator time and a prolonged in-
hospital stay [5,7]. Moreover, CIP is associated with in-
creased in-hospital mortality [8].
The current gold standard for diagnosis of CIP and
CIM in the ICU setting consists of a careful neurological
examination together with nerve conduction studies and
electromyography (EMG) [9]. Typical electroneurographic
signs of CIP are reductions of the amplitude of compound
muscle action potentials as well as sensory nerve actionLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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motor action potential develops within 2 to 5 days [12].
However, there is no direct relationship between ICUAW
and electrophysiological (muscle or nerve) abnormalities
with a high prevalence of electrophysiological abnormal-
ities early on in critical illness. In addition, assessment of
Medical Research Council scores of muscle strength and
classical EMG examinations beyond the detection of spon-
taneous activity often cannot reliably be performed since,
in the acute phase of severe sepsis, patients are as a rule
unconscious and hence uncooperative.
Yet, early detection of critical illness neuromyopathy is
beneficial for improving standards of care [1,13,14]. Ac-
cordingly, there is a pressing need for easily applicable
and non-invasive instruments for evaluation of muscle
state in critically ill patients.
Muscle ultrasound has shown growing promise in the
diagnosis of neuromuscular diseases [15-18]. Axonal
nerve damage in CIP and direct muscle impairment in
CIM cause changes in muscle structure as well as in-
duce spontaneous muscle activity [1,2]. Both struc-
tural changes and spontaneous activity are detectable using
muscle ultrasound.
We performed a first feasibility study in patients with
electrophysiological proven critical illness neuromyopathy
and clinical signs of ICUAW to evaluate whether muscle
ultrasound allows visualization of changes in the muscle
echotexture during the early course of sepsis.Materials and methods
Patients
Between October 2011 and August 2012 we prospect-
ively performed standardized muscle ultrasound exami-
nations in patients with either severe sepsis or septic
shock. All patients were enrolled in the NeuroSOS-
NERVE Study (German Clinical Trials Register [DRKS-ID:
DRKS00000642]). The study is still ongoing and fo-
cuses on the impairment of small sensory nerve fibers
in skin biopsies. The study has been approved by the local
ethics committee (Ethics Commission of the Friedrich-
Schiller-University Jena, No. 2771-02/10). Written in-
formed consent was obtained from all patients or their
legal representative.
Severe sepsis and septic shock were defined according
to published criteria [19,20]. Patient eligibility was screened
daily by trained ICU research nurses. Exclusion criteria
comprised a history of neuromuscular disorders (for ex-
ample, polyneuropathy, myopathy, motor neuron disease,
and others), known alcohol abuse, high-dose steroid ther-
apy before sepsis. Furthermore, we excluded patients with
protracted critical illness – that is, an ICU stay >8 days
prior to enrollment – to ensure a more homogeneous
population with acute critical illness.All patients were examined between days 2 and 5 (visit 1)
and on day 14 (visit 2) after the onset of severe sepsis or
septic shock, respectively. Each patient received a clinical
neurological examination including evaluation of Medical
Research Council muscle strength and Rankin score, and
underwent muscle ultrasound as well as nerve conduction
studies. The same clinical neurological examination and
muscle ultrasound protocol were undertaken in a group
of healthy controls of comparable age.Ultrasound protocol
Ultrasonography was performed using a 9 to 13 MHz
probe real-time linear array scanner (Siemens Acuson,
Erlangen, Germany). The initial settings (as contrast) were
kept constant during all examinations excluding the
depth, which was altered individually to visualize the
complete muscle. Performers of ultrasound examination
were blinded to the clinical and electrophysiological pa-
rameters. Ultrasonography was performed bilaterally in
different muscles of the upper and lower limbs. Patients
were examined in the supine position with extended
arms and legs and relaxed muscles [21,22]. The muscles
were scanned in both axial and longitudinal planes, and
each muscle was evaluated at standardized anatomical
points (in detail: biceps brachii and quadriceps femoris
muscles at the midline between origin and insertion, the
extensor muscles of the forearms at the first third of the
distance between the elbow and processus styloideus
radii, and the tibialis anterior muscle at the first third be-
tween the knee and malleolus lateralis).
Assessment of ultrasonic muscle echogenicity was
one of the key parameters of the study. Compression
of the tissue and oblique scanning were avoided be-
cause of the risk of an artificial change in muscle echo-
texture. Ultrasonic echogenicity was graded according to
Heckmatt and colleagues [23]. This score differentiates
ultrasonic echogenicity semiquantitatively into four grades
(Figure 1). A higher grade of echotexture with reduced
or lost bone signal correlates to the severity of muscle
impairment.
Ultrasonic detection of muscle fasciculations was the
second key parameter. Each muscle was scanned over a
time period of 10 seconds at three different measurement
points without moving the probe, as described previously
[24,25]. Fasciculations are visible as short twitches of bun-
dles of muscle fibers. They were classified as spontaneous
activity if they appeared at least twice. Fasciculations can
easily be distinguished from other movements such
as arterial pulsations (unifocal, rhythmic) or voluntary
movements (involving the entire muscle) [26]. Analysis of
ultrasound data was performed both online and offline.
Complete ultrasonographic examination of each patient
necessitated about 25 minutes.
Figure 1 Ultrasonic cross-sections through the tibialis anterior
muscles showing different grades in echogenicity as defined by
the Heckmatt score [23]. (A) Normal echo intensity with starry-night
aspect with distinct bone echo in a healthy control. (B) Increased
echo intensity with normal bone echo in a septic patient at day 4.
(C) Increased echo intensity with reduced bone signal in a septic
patient at day 14. (D) Increased echo intensity and loss of bone
signal in a septic patient at day 14.
Table 1 Demographics and baseline characteristics of
patients (n = 28)
Age (years) 69.5 (61.5 to 75.25)
Male gender 25 (89.29%)
Body mass indexa 27.7 ± 7.1
APACHE II scoreb 22.5 ± 6.5
Septic shock 21 (75%)
Duration of ventilation (days) 20.5 ± 13.7
Days of stay on ICU 35.1 ± 71.3
Days of stay on ICU before sepsis 3.0 ± 4.7
Renal replacement therapy 12 (42.86%)
Days with renal replacement therapy 4.4 ± 7.8
Days with vasopressors 11.14 ± 9.55
Days with sedation 8.9 ± 8.7
Cumulative doses
Midazolam (mg) 6,930.3 ± 1,153.8
Propofol (mg) 10,784.8 ± 13,749.6
Ketamine (mg) 11,52.1 ± 3,347.1
Clonidine (μg) 1,506.4 ± 4,118.7
Days with opioids 8.9 ± 8.8
Cumulative doses
Sufentanyl (mg) 14.9 ± 25.0
Morphine (mg) 233.0 ± 147.9
Preexisting conditionsc
History of diabetes 9 (32.1%)
Heart failure 7 (25.0%)
Cerebrovascular disease 10 (35.7%)
Renal dysfunction 4 (14.3%)
Chromic obstructive pulmonary disease 4 (14.3%)
Liver cirrhosis 1 (3.6%)
History of cancer 3 (10.7%)
Immunosuppression 2 (7.1%)
Recent surgical history
Elective surgery 1 (3.6%)
Emergency surgery 6 (21.4%)
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Additionally, standardized nerve conduction studies were
carried out using a portable electro-neurophysiologic device
(Synergy 15.0; VIASYS Healthcare UK Ltd, CareFusion
Germany, Hoechberg, Germany). The right median nerve,
the right tibial nerve, the left fibular nerve, and both sural
nerves were measured. Motor and sensory nerve re-
sponses were assessed for the right median nerve,
motor responses only for the tibial and fibular nerve, and
sensory nerve responses for both sural nerves.
Electroneurographic criteria for the diagnosis of CIP were
a reduction in the amplitude of compound muscle action







Wound infection 1 (3.6%)
Cerebral empyema 1 (3.6%)
Hospital mortality 10 (35.7%)
Data presented as median, (interquartile range), n (%) or mean ± standard
deviation. APACHE, Acute Physiology and Chronic Health Evaluation.
aCalculated as weight in kilograms divided by height in meters squared.
bMissing subscores were counted as 0. The scale score range is from 0 to 71,
with higher scores indicating a greater severity of illness.
cMultiple entries per patient possible.Statistical analysis
A grading of overall echotexture was calculated as the
mean of the grades of echotexture analyzed in the four
different regions (proximal and distal arm, proximal and
distal leg). To compare the mean echotexture of controls
and patients (day 4 and 14), Wilcoxon rank-sum tests
were used. For the comparison of the mean echotexture
of patients at day 4 and 14, Wilcoxon signed-rank tests
were applied because samples are paired. Patients with-
out measurements at day 14 due to death were thus
excluded. The Cochran–Armitage test for trend was ap-
plied for comparison of the number of regions with
detected fasciculations between healthy controls and pa-
tients (measurements at days 4 and 14). Since this study
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testing was performed.
Results
Baseline characteristics of patients
A total of 28 patients with sepsis (21 with septic shock,
seven with severe sepsis) were enrolled (median age 69.5
years, interquartile range 61.5 to 75.25 years; 25 male,
three female). Six patients died before the second visit at
day 14. Furthermore, 26 healthy controls (median age 64
years, interquartile range 61 to 76 years; 12 male, 14
female) were also examined.
The baseline characteristics of the patients and micro-
biological findings are presented in Tables 1 and 2. None
of the patients was exposed to risk factors for CIM, such
as high-dose steroids or neuromuscular blocking agents
(exclusion criteria of the study). All patients had lost or
at least attenuated muscle reflexes and also showed sig-
nificant muscle weakness (Table 3). Twenty of the 28 pa-
tients (71%) were mechanically ventilated at the first
visit and 10 out of 22 patients (45.5%) at the second
visit. Most of the patients received vasopressors, sedative
drugs, and opioids (Table 3).
Nerve conduction studies
Nerve conduction studies were performed in 26 patients at
day 4 and in 18 patients at day 14. All patients exhibited
the typical electrophysiological characteristics of CIP – that
is, reductions of amplitudes of compound motor action po-
tential and sensory nerve action potential (see Additional
file 1) – in contrast to relatively small reductions in nerve







Staphylococcus aureus 0 1 1
Coagulase-negative staphylococcus species 1 0 0
Enterococci 0 0 8
Streptococci group A to C, G 0 0 0
Streptococcus pneumoniae 0 0 0
Other streptococci 1 0 0
Other aerobic gram-positive bacteria 1 0 0
Escherichia coli 2 0 1
Enterobacter 0 0 1
Klebsiella 3 0 1
Proteus spp. 0 0 1
Other gram-negative bacteria 0 0 1
total 8 1 14
aMultiple entries per patient possible.Local reference values were used as lower limits for elec-
troneurography amplitudes. All patients measured thus suf-
fered from CIP according to electroneurographic criteria.
Ultrasonic muscle echogenicity
Ultrasonic echogenicity was graded semiquantitatively
according to Heckmatt and colleagues [23]. Figure 1
shows some examples of different grades of echotexture
in the tibialis anterior muscle. Interimage measurements
demonstrated an intraclass correlation coefficient of
0.915 between raters, while the intrarater intraclass cor-
relation coefficient was 0.972.
Figure 2 illustrates the distribution of muscle echotexture
and fasciculations in controls and patients at day 4
and day 14 separately in the four anatomical regions
analyzed. All echotexture scores of the four muscle re-
gions examined were averaged (Figure 3) to generate a
mean echotexture score. Ninety-two percent of the con-
trols revealed a normal mean echotexture (grade 1 or
1.25). Seventy-five percent of the patients showed a mean
echotexture greater than 1.5, which was the maximal
value found in the control group. A significant difference
in mean muscle echotexture between patients and con-
trols was found at day 4 and day 14 (both P <0.001). In
addition, the mean grades of muscle echotexture in the
patient group increased between day 4 and day 14, but
did not reach statistical significance (P = 0.085).
To avoid averaging the semiquantitative scores of
echotexture over all muscles analyzed, single trend tests
per visit and anatomical muscle region were performed
separately and all Cochran–Armitage tests for trend










0 1 0 3
0 0 0 1
0 1 0 9
0 1 0 1
0 0 1 1
2 0 0 3
0 0 0 1
2 2 0 7
0 0 0 1
1 0 0 5
0 0 0 1
0 0 0 1
5 5 1 34
Table 3 Neurological characteristics of patients at the two visits
Visits Day 4 Day 14
Number of patients 28 22
Mechanical ventilation 20 (71.4%) 10 (45.5%)
Mean cumulative fluid balance In: 21,935 ml In: 66,028 ml
Out: –16,533 ml Out: –64,969 ml
Net: 5,402 ml Net: 1,059 ml
Rankin score Rankin score Number Rankin score Number
2 0 (0%) 2 1 (4.6%)
3 3 (10.7%) 3 2 (9.1%)
4 2 (7.1%) 4 4 (18.2%)
5 23 (82.1%) 5 12 (68.2%)
Muscle strength proximal arm MRC score Number MRC score Number
0 to 1 18 (64.3%) 0 to 1 9 (40.9%)
2 4 (14.3%) 2 2 (9.1%)
3 3 (10.7%) 3 6 (27.3%)
4 3 (10.7%) 4 4 (18.2%)
5 0 (0%) 5 1 (4.5%)
Muscle strength distal arm MRC score Number MRC score Number
0 to 1 20 (71.4%) 0 to 1 9 (40.9%)
2 1 (3.6%) 2 2 (9.1%)
3 1 (3.6%) 3 5 (22.7%)
4 4 (14.3%) 4 5 (22.7%)
5 2 (7.1%) 5 1 (4.5%)
Muscle strength proximal leg MRC score Number MRC score Number
0 to 1 19 (67.9%) 0 to 1 8 (36.4%)
2 4 (14.3%) 2 5 (22.7%)
3 2 (7.1%) 3 4 (18.2%)
4 3 (10.7%) 4 4 (18.2%)
5 0 (0%) 5 0 (0%)
Muscle strength distal leg MRC score Number MRC score Number
0 to 1 19 (67.9%) 0 to 1 10 (45.5%)
2 2 (7.1%) 2 2 (9.1%)
3 2 (7.1%) 3 2 (9.1%)
4 5 (17.9%) 4 6 (27.3%)
5 0 (0%) 5 2 (9.1%)
Biceps reflex Number Number
Absent 15 (53.6%) Absent 13 (59.1%)
After reinforcement 3 (10.7%) After reinforcement 3 (13.6%)
Attenuated 10 (35.7%) Attenuated 5 (22.7%)
Normal 0 (0%) Normal 1 (4.5%)
Patellar reflex Number Number
Absent 18 (64.3%) Absent 9 (40.9%)
After reinforcement 4 (14.3%) After reinforcement 2 (9.1%)
Attenuated 6 (21.4%) Attenuated 10 (45.5%)
Normal 0 (0%) Normal 1 (4.5%)
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Table 3 Neurological characteristics of patients at the two visits (Continued)
Ankle jerk reflex Number Number
Absent 26 (92.9%) Absent 18 (81.8%)
After reinforcement 1 (3.6%) After reinforcement 1 (4.5%)
Attenuated 1 (3.6%) Attenuated 2 (9.1%)
Normal 0 (0%) Normal 1 (4.5%)
Patients with drugs Sufentanyl 15 (53.6%) Sufentanyl 8 (36.4%)
Midazolam 6 (21.4%) Midazolam 4 (0.2%)
Propofol 6 (21.4%) Propofol 0 (0%)
Clonidine 6 (21.4%) Clonidine 1 (0.05%)
Vasopressors 20 (71.4%) Vasopressors 8 (36.4%)
MRC, Medical Research Council.
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Fasciculations were sonographically detected in differ-
ent anatomical regions in the patient group, but also in
38% in the distal leg muscles of the healthy controls
(Figure 2). In all anatomical regions analyzed, healthy
controls revealed the lowest number of detected fascicula-
tions, whilst patients at day 14 had more fasciculations
than patients at day 4 as fasciculations increased over time
of sepsis.
A fasciculation score that ranged from 0 to 4 and sim-
ply counted the anatomical regions with ultrasonically
detected fasciculations was conceived (that is, 0 to 4 re-
gions with fasciculations out of four muscle regions). TheFigure 2 Frequency of ultrasonographic echogenicity grades
and detection of fasciculations. Frequency (%) of different
ultrasonographic echogenicity grades as defined by the Heckmatt
score [23] and detection of fasciculations in different anatomical
regions for patients at day 4 and day 14 and for controls.Cochran–Armitage test for trend for comparing healthy
controls versus patients revealed P = 0.080 at day 4
(Table 4) and P = 0.002 at day 14 (Table 5).Regional and anatomical relationships
In addition, a weak correlation was found between the
mean echogenicity score and the fasciculation score at both
day 4 (Pearson correlation coefficient 0.399, P = 0.001) and
day 14 (Pearson correlation coefficient 0.615, P <0.001).
Comparison of echogenicity between proximal and dis-
tal muscles in the patient group did not reach significance
at both visits, while detected fasciculations differed signifi-
cantly between proximal and distal muscles of the arm
and the leg at day 14 (McNemar’s test for paired samples,
P = 0.008 each). Fasciculations were detected more fre-
quently in the distal than in the proximal muscles in the
patients at day 14.
Figure 4 depicts a magnetic resonance imaging scan (1.5
Tesla) of the thigh in a sepsis patient at day 14 in compari-
son with a healthy control, to illustrate structural changesFigure 3 Boxplots of mean echotexture over four anatomical
regions. For patients, additional parallel coordinate plots are shown
to illustrate differences over time. Each patient is represented by a
grey circle. Contr., control; Pat., patient.
Table 4 Number of muscle regions with fasciculations in
proximal and distal upper and lower extremities in
patients at day 4 versus controls
Number of muscle regions with fasciculations Total
0/4 1/4 2/4 3/4 4/4
Patients 10 9 5 1 3 28
Controls 15 8 1 1 1 26
Total 25 17 6 2 4 54
Cochran–Armitage test for trend: χ2 = 3.056, degrees of freedom = 1, P = 0.080.
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seen in magnetic resonance imaging.
Discussion
Results of this first pilot study suggest a promising role for
bedside ultrasound as an additive non-invasive procedure
for detecting changes in muscle architecture in patients
with either septic shock or severe sepsis. Several studies
have demonstrated that muscle ultrasound is able to reli-
ably detect pathological changes [15-18] such as muscle at-
rophy, fatty infiltration, and intramuscular fibrosis [28,29].
The combination of static and dynamic images in B-mode
and M-mode [30,31] enables the detection of spontaneous
muscle activity, so that muscle fasciculations can be visual-
ized with higher sensitivity by ultrasound compared with
EMG measurements [14,24,31].
Limitations of the study
Our study has several limitations. First, patient numbers
were small and patient age was relatively high. Second,
one-third of the patients had coexistent diabetes mellitus,
which may enhance susceptibility for neuropathic disorders
such as diabetic polyneuropathy. However, preexisting
known neuropathy or myopathy were exclusion cri-
teria for the study. Third, patients and controls were not
sex-matched as we did not focus on sex-dependent dif-
ferences herein. Finally, the timeframe for initial assess-
ment (that is, 2 to 5 days after onset of sepsis) was
relatively broad and the ICU stay before onset of severe
sepsis varied between patients, which may have contrib-
uted to alterations in the muscle state between study visits.Table 5 Number of muscle regions with fasciculations in
proximal and distal upper and lower extremities in
patients at day 14 versus controls
Number of muscle regions with fasciculations Total
0/4 1/4 2/4 3/4 4/4
Patients 4 6 5 5 2 22
Controls 15 8 1 1 1 26
Total 19 14 6 6 3 48
Cochran–Armitage test for trend: χ2 = 9.590, degrees of freedom = 1, P = 0.002.Ultrasound characteristics were restricted to semiquantita-
tive grading of echogenicity and the detection of fas-
ciculations. Additional parameters such as atrophy of the
muscles that can be evaluated by diameter, area, and vol-
umes of the muscles measured in ultrasonic cross-sections
were not considered.
Echotexture grading using a semiquantitative scale
may be subject to technical misinterpretation in con-
trast to objective, user-independent algorithms for image
analysis [21,26]. However, the Heckmatt score used in
our study is a rapid applicable bedside technique that
can be easily used in the intensive care setting. More-
over, intrarater and interrater reliability measurements
in this study were good and did not differ from the
interrater and intrarater intraclass correlation coefficients
of muscle ultrasound measurements described in the
literature [32,33].
Muscle echogenicity
We found significant alterations in muscle echotexture in
the early stage of sepsis compared with healthy controls.
Similar changes have also been described in a recent study
of 16 patients with acute respiratory distress syndrome
[34]. The marked changes in muscle echotexture during
sepsis may refer to muscle edema due to capillary leak in
the acute stage and to fibrosis and fatty degeneration in the
subacute stage of sepsis.
Excessive fluid resuscitation with positive fluid balance
in septic shock patients may partly account for un-
specific muscle edema in the acute stage of sepsis. Changes
in superficial tissues due to edema may affect the interpret-
ation of muscle images and may also cause artificial
amplitude reductions in nerve conduction measurements.
However, in the later stages of severe sepsis (that is, on day
14 in our study), fluid balances are more balanced [35].
In our study, mean cumulative fluid balances at day 4
and day 14 were positive (5.4 l and 1 l respectively; see
Table 3). Since different tissues may lose fluid at differ-
ent rates, it is difficult to clarify from our data whether
muscle echogenicity may be caused by edema or genuine
muscle impairment. However, the significance of tissue
edema in the assessment of muscle echogenicity may be
overestimated, since tissue edema cannot alter the bone
signal in contrast to fibrous tissue, which also contrib-
utes to the grading in the Heckmatt score [36]. It has
been shown earlier that ultrasonic echogenicity scores
mainly correlate to fibrous tissue content in muscle bi-
opsies [28], and the detection of fasciculations per se
cannot be altered by edema.
Since the muscle echotexture score increased in our
study from day 4 to day 14 in the presence of decreasing
fluid balances at day 14, a specific structural damage in
muscle architecture can be assumed. This is supported
by findings from muscle magnetic resonance imaging in
Figure 4 Muscle magnetic resonance imaging (1.5 Tesla) of a sepsis patient and a healthy control. Left: sepsis patient at day 14. Right:
healthy control. Short TI inversion recovery (STIR) is a magnetic resonance imaging (MRI) sequence to suppress the signal from fat, so that
especially edema can be seen in the muscle. The images demonstrate that at day 14 after onset of severe sepsis the structural changes in the
muscle (atrophic and fibrous changes) dominate over edematous changes. Ultrasonic sections of the same subjects through the rectus femoris
muscle (large arrows) are shown at the bottom. The corresponding areas in MRI are marked as rectangles. The difference in echogenicity of the
muscle can clearly be seen. Moreover, the bone signal in the patient begins to blur (small arrows).
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muscle architecture without tissue edema (Figure 4).
Structural muscle changes can be due to muscle wasting
[37], which may be caused by immobility, but also by dir-
ect muscle impairment in CIM and indirect muscle im-
pairment in CIP, due to denervation [38]. Muscle wasting
may enhance echogenicity due to a relative increase of fi-
brous tissue caused by a decrease of muscle fiber volume.
The proportion of myopathy, neuropathy, and immobility-
induced atrophy could not be definitely proven in our
study. Nerve conduction studies, however, revealed that
the majority of our patients suffered from CIP, since motor
as well as sensible nerve fibers were impaired according to
electrophysiological evidence. The additional existence of
CIM could not been ruled out, as CIP and CIM often
co-occur [14,39], and muscle biopsies or direct muscle
stimulation [40,41] were not performed to distinguish CIP
from CIM.Fasciculations
Our study suggests that ultrasound is also capable of
detecting muscle fasciculations in the early course of
sepsis. Muscle fasciculations represent spontaneous activity
in the muscle, which is a sign of increased excitability of
the impaired motor nerves. Although fasciculations have
not been examined using EMG in our study, it is well
established that detection of fasciculations is more sensitive
using ultrasound than by EMG, because a larger muscle
area can be analyzed [24,42].
Previously it has been shown that the median time to
develop spontaneous activity in EMG is 21 days after
ICU admission [43]. In contrast, we observed muscle fas-
ciculations after only 4 days. Such early changes might be
more likely to arise in CIM [44]. Since the mean length of
ICU stay before onset of sepsis was 3 days (see Table 1),
many patients were already critically ill before enrollment.
This may also account for the ‘relatively’ early detection of
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have already been present before severe sepsis as sepsis is
not the only risk factor for CIMN.
Although more fasciculations were detectable in septic
patients at day 4 compared with controls, the difference
did not reach statistical significance. Furthermore, fascicu-
lations were also apparent in a considerable number of
controls. This may be due to pre-existing subclinical nerve
lesions in older subjects in the control group; for example,
caused by prevailing radiculopathy (L5 and S1) due to lum-
bar disc degeneration most notably in the distal leg.
Nevertheless, in the patient group fasciculations in-
creased significantly over different muscle regions over
time. The increased involvement of arm muscles over time
may be a sign of sepsis-induced muscle alteration.
There was a weak correlation between mean echo-
genicity score and fasciculation score, which points to
an interrelationship between functional signs of axonal
denervation and changes of muscle structure.
Link to function
Electrophysiological changes in critically ill patients may
evolve early and also be rapidly reversible [1], so that
these changes do not directly reflect functional outcome
of the patients. This is also due to excitability changes in
muscle and axonal membranes, which cause early func-
tional impairments before structural damage occurs [38].
At this early time point ICUAW can be reversible, as is
seen by the fact that many patients recover well.
In our study neither nerve conduction studies nor
muscle ultrasound correlated significantly with function
(that is, Medical Research Council scores, Rankin score,
weaning times, and so forth; not shown in detail). How-
ever, our patient group consisted of severely ill patients
many of whom were mechanically ventilated and se-
dated, and hence clinical muscle strength could not be
reliably measured and follow-up examinations of func-
tional impairments were not performed. More informa-
tion is therefore needed to correlate functional outcome
over a longer follow-up period in association with ultra-
sonic measurements.
Conclusions
In summary, we present a first feasibility study compar-
ing muscle ultrasound in patients with severe sepsis and
healthy controls. We detected changes in muscle echo-
genicity in the early course of sepsis, while fasciculations
evolved later. Muscle ultrasound is an easily applicable,
non-invasive diagnostic tool for use in the intensive care
setting and may facilitate bedside assessment of the
muscle state in critically ill patients. Muscle ultrasound
adds to neurophysiological testing knowledge with re-
spect to morphological changes of muscles and may
prove to be a screening tool for use prior to subjectingpatients to more invasive techniques such as EMG and/
or muscle biopsy. To date, the impact of muscle ultra-
sound on the prediction of functional outcome is un-
clear. Further studies are needed to describe the detailed
time course of ultrasonic muscle changes and the evolve-
ment of spontaneous activity in sepsis in relation to the
functional clinical outcome. Here, a reliable differentiation
between CIP and CIM (for example, using direct muscle
stimulation and muscle biopsies) as well as a comparison
between critically ill patients with and without ICUAW
is required.Key messages
 Changes in muscle echogenicity can be detected
early in the course of sepsis using muscle ultrasound.
 Muscle fasciculations are also detectable and evolve
later.
 Muscle ultrasound might be a useful, easily applicable,
non-invasive early screening tool prior to subjecting
patients to more invasive techniques such as EMG
and/or muscle biopsy.Additional file
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